Long-term Outcomes of Oral Decitabine/Cedazuridine Plus Venetoclax in Older or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia

Long-term Outcomes of Oral Decitabine/Cedazuridine Plus Venetoclax in Older or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia

Oral decitabine/cedazuridine plus venetoclax provides an effective, fully oral frontline therapy for older or unfit patients with AML, showing encouraging response rates and manageable safety with long-term follow-up, highlighting particular challenges in secondary AML.
Ten-Year Comparative Outcomes of Sacrospinous Hysteropexy With Mesh Versus Vaginal Hysterectomy for Uterovaginal Prolapse: Long-Term Efficacy and Safety

Ten-Year Comparative Outcomes of Sacrospinous Hysteropexy With Mesh Versus Vaginal Hysterectomy for Uterovaginal Prolapse: Long-Term Efficacy and Safety

This 10-year randomized clinical trial reveals that sacrospinous hysteropexy with mesh offers lower failure rates and comparable safety to vaginal hysterectomy in treating uterovaginal prolapse, supporting its use as an effective uterine-preserving alternative.